FindTrial
Sign In

A prospective observational study to assess the role of 18F-FDG PET-CT in evaluating myocardial inflammation immediately after Percutaneous Angioplasty with Myocardial Intervention (PAMi) in patients with coronary artery disease.

A Study to assess role of 18F-FDG PET-CT immediately after PAMI in a case of coronary artery disease - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/09/094766
Enrollment
25
Registered
2025-09-15
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I20-I25- Ischemic heart diseases

Interventions

Intervention1: Primary angioplasty in myocardial infarction: primary angioplasty done in case of acute ST elevation myocardial infarction as for routine treatment protocol

Sponsors

Dr Vigneshwaran M
Lead Sponsor
Dr Bharat S Sambyal
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients who qualify for a need of diagnostic angiography followed by angioplasty 1. Acute ST-elevation myocardial infarction 2. Non ST-elevation myocardial infarction 3. Unstable angina 4. Stable angina 5. Anginal equivalent 6. High risk stress test findings

Exclusion criteria

Exclusion criteria: un willing for 18F-FDG PET-CT Pregnant women Psychiatry patients claustrophobic

Design outcomes

Primary

MeasureTime frame
Improvement of Ejection fraction and reperfusionTimepoint: Improvement of Ejection fraction and reperfusion—

Secondary

MeasureTime frame
To check for improvement in ejection fraction and reperfusion. To correlate FDG uptake with procedural details (number of vessels involved, stent placement, and duration). To assess association between post-PAMi inflammation and serum cardiac biomarkers (e.g., Troponin I, CK-MB, hs-CRP). To explore predictive value of early PET-CT findings in short-term outcomes (e.g., recurrent angina, re-hospitalization within 30 days). Timepoint: 3-6 months—

Countries

India

Contacts

Public ContactDr Bharat S Sambyal

INHS Asvini

waranthedon@gmail.com8698751411

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026